Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles
Authors:
- 21 October 2010
- journal article
- review article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 7 (6) , 1921-1929
Abstract
The past decade has seen momentous development in brain cancer research in terms of novel imaging-assisted surgeries, molecularly targeted drug-based treatment regimens or adjuvant therapies and in our understanding of molecular footprints of initiation and progression of malignancy. However, mortality due to brain cancer has essentially remained unchanged in the last three decades. Thus, paradigm-changing diagnostic and therapeutic reagents are urgently needed. Nanotheranostic platforms are powerful tools for imaging and treatment of cancer. Multifunctionality of these nanovehicles offers a number of advantages over conventional agents. These include targeting to a diseased site thereby minimizing systemic toxicity, the ability to solubilize hydrophobic or labile drugs leading to improved pharmacokinetics and their potential to image, treat and predict therapeutic response. In this article, we will discuss the application of newer theranostic nanoparticles in targeted brain cancer imaging and treatment.Keywords
This publication has 78 references indexed in Scilit:
- EGFRvIII Antibody–Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging–Guided Convection-Enhanced Delivery and Targeted Therapy of GlioblastomaCancer Research, 2010
- Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimagingParticle and Fibre Toxicology, 2010
- Multifunctional magnetic nanoparticles for targeted deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Multifunctional Magnetic Nanocarriers for Image-Tagged SiRNA Delivery to Intact Pancreatic IsletsTransplantation, 2008
- Multifunctional magnetic nanoparticles for targeted imaging and therapy☆Advanced Drug Delivery Reviews, 2008
- Tumor-Targeted Drug Delivery and MRI Contrast Enhancement by Chlorotoxin-Conjugated Iron Oxide NanoparticlesNanomedicine, 2008
- Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug DeliveryACS Nano, 2008
- In Vivo MRI Detection of Gliomas by Chlorotoxin‐Conjugated Superparamagnetic NanoprobesSmall, 2008
- Fluorescent Nanoparticle Uptake for Brain Tumor VisualizationNeoplasia, 2006
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989